Technivie

Generic name: Ombitasvir, Paritaprevir, And Ritonavir
Drug class: Antiviral combinations

Usage of Technivie

Technivie contains a comination of ombitasvir, paritaprevir, and ritonavir. Ombitasvir, paritaprevir, and ritonavir are antiviral medicines that prevent hepatitis C virus (HCV) from multiplying in your body.

Technivie is used to treat genotype 4 chronic hepatitis C in adults without cirrhosis or with a certain type of cirrhosis (compensated cirrhosis).

Technivie is given together with another drug called ribavirin.

Technivie side effects

Get emergency medical help if you have signs of an allergic reaction to Technivie: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have new or worsening symptoms such as:

confusion;

loss of appetite, upper stomach pain;

dark urine, clay-colored stools; or

jaundice (yellowing of the skin or eyes).

Common Technivie side effects may include:

nausea;

headache, mood changes;

muscle or joint pain;

dizziness, feeling weak or tired;

sleep problems (insomnia); or

itching or other skin problems.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Technivie

You should not use Technivie if you are allergic to ombitasvir, paritaprevir, or ritonavir, or if you have:

moderate to severe liver problems; or

if you have ever had a severe skin rash after taking ritonavir (Norvir).

If you take Technivie with ribavirin: There may be other reasons you should not take this combination treatment. Tell your doctor about all your medical conditions.

Some medicines can interact with ombitasvir, paritaprevir, and ritonavir and should not be used at the same time. Your doctor may need to change your treatment plan if you use any of the following drugs:

alfuzosin;

colchicine;

dronedarone;

efavirenz;

ranolazine;

rifampin;

sildenafil (Revatio), when taken for pulmonary artery hypertension (PAH);

St. John's wort;

oral midazolam (Versed), or triazolam;

antipsychotic medicine - lurasidone, pimozide;

birth control pills or patches - Lo Loestrin FE, Norinyl, Ortho Tri-Cyclen Lo, Ortho Evra, and others;

hormone replacement therapy such as Fem HRT;

a vaginal ring such as NuvaRing;

cholesterol-lowering medicine - gemfibrozil, lovastatin, simvastatin (Zocor, Vytorin, Simcor);

ergot medicine - dihydroergotamine, ergotamine, ergonovine, methylergonovine; or

seizure medicine - Carbamazepine, phenytoin, phenobarbital.

Before you start taking Technivie, you must stop using medicine that contains ethinyl estradiol. This includes certain birth control pills or hormone replacement medicines. Ask your doctor about using non-hormonal birth control (condom, diaphragm with spermicide) to prevent pregnancy while taking Technivie and for 2 weeks after your treatment ends.

To make sure this medicine is safe for you, tell your doctor if you have ever had:

hepatitis B;

liver problems other than hepatitis C;

heart disease;

HIV (human immunodeficiency virus);

a liver transplant; or

if you use a blood thinner (warfarin, Coumadin, Jantoven) and you have routine "INR" or prothrombin time tests.

Technivie is used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby.

If you are a woman, do not use ribavirin if you are pregnant. You may need to have a negative pregnancy test before taking ribavirin and every month during your treatment.

If you are a man, do not use ribavirin if your sexual partner is pregnant. An unborn baby could be harmed if you have sex with a pregnant woman while you are taking ribavirin.

While taking Technivie with ribavirin, use at least 2 effective forms of birth control to prevent pregnancy, whether you are a man or a woman. Ribavirin use by either parent may cause birth defects.

Keep using 2 forms of birth control for at least 6 months after your last dose of ribavirin. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using ribavirin.

It may not be safe to breast-feed while using ombitasvir, paritaprevir, and ritonavir. Ask your doctor about any risk.

Technivie is not approved for use by anyone younger than 18 years old.

Relate drugs

How to use Technivie

Usual Adult Dose for Chronic Hepatitis C:

2 tablets orally once a day (in the morning) Recommended Regimen and Duration of Therapy: -Genotype 4, without cirrhosis or with compensated cirrhosis (Child-Pugh A): Ombitasvir/paritaprevir/ritonavir plus ribavirin for 12 weeks ---Therapy-naive patients without cirrhosis who cannot take or tolerate ribavirin: May consider ombitasvir/paritaprevir/ritonavir for 12 weeks Comments: -The manufacturer product information should be consulted for ribavirin dosing recommendations; the manufacturer product information for ribavirin should be consulted regarding dose adjustments. Use: In combination with ribavirin, for the treatment of patients with genotype 4 chronic HCV infection without cirrhosis or with compensated cirrhosis

Warnings

Do not use Technivie together with ribavirin if you are pregnant, or if you are a man and your sexual partner is pregnant.

Before you start taking Technivie, you must stop using certain birth control pills or hormone replacement medicines. Ask your doctor about using non-hormonal birth control to prevent pregnancy.

If you have ever had hepatitis B, this medicine can cause this condition to come back or get worse. You will need frequent blood tests to check your liver function.

Technivie is used in combination with other medication. Read the medication guide or patient instructions provided with each medication in your combination therapy. Do not change your doses or medication schedule without your doctor's advice.

What other drugs will affect Technivie

When you start or stop taking Technivie, your doctor may need to adjust the doses of any other medicines you take on a regular basis.

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Many drugs can interact with ombitasvir, paritaprevir, and ritonavir, and some drugs should not be used together. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Tell your doctor about all medicines you use, and those you start or stop using during your treatment with Technivie. Give a list of all your medicines to any healthcare provider who treats you.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.